EIT Food Report: Consumer Trust Gap Hinders Novel Ingredient Adoption in Europe
New EIT Food research reveals European consumer openness to food innovation improved slightly (28% to 31%), yet deep distrust remains a critical barrier for novel ingredients like precision-fermented proteins and insect-based compounds. Brand owners must prioritise tangible benefits and trust-building over technical explanations.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
London, United Kingdom — 20 August 2026
European consumer receptivity to food innovation increased marginally from 28% to 31% between 2024 and 2025, according to EIT Food's 'Trust in innovation: Between familiarity and fear' report. However, this modest gain masks significant resistance to novel food technologies, including precision fermentation-derived ingredients and insect-based proteins, which have direct implications for the supplement sector's ingredient pipeline. The research, based on 19,954 adult responses across 18 European countries, identifies consumer trust as the primary determinant for market acceptance.
A critical finding is the stark divergence in acceptance based on trust levels: 38% of high-trust consumers are open to innovation, plummeting to just 6% among those with low trust in the food system. This trust gap persists even for consumers motivated by health or sustainability, where acceptance rates drop from 32% (high trust) to 8% (low trust) for health-oriented individuals, and from 35% to 10% for sustainability-focused consumers. This highlights that simply aligning with perceived consumer values like health or sustainability is insufficient without first establishing foundational trust in the source and regulatory oversight.
Age further segments market potential; nearly 40% of 18-34 year olds show openness to new food products, contrasting sharply with less than 20% of consumers aged 55 and over. This demographic disparity suggests that product development and marketing for novel ingredients in supplements should initially target younger, more receptive cohorts, or focus on familiar formats to mitigate adoption barriers for older demographics.
EIT Food recommends that ingredient suppliers and supplement manufacturers pivot from technical explanations of ingredient provenance to articulating tangible consumer benefits. Emphasising taste, pleasure, and direct relevance to daily life, rather than the scientific novelty, is crucial. Integrating novel ingredients into familiar product forms and usage occasions could accelerate acceptance, particularly for those falling under the EU's novel food framework, which requires rigorous safety assessments but does not guarantee market success.
What this means for United Kingdom
UK supplement manufacturers must proactively address the consumer trust deficit to integrate novel ingredients effectively. Focus on transparency in sourcing and manufacturing, leveraging third-party certifications and robust in-house quality control to build confidence, particularly given the 6% acceptance rate for low-trust consumers. Formulators should prioritise integrating novel compounds into familiar delivery formats, such as capsules or powders, over introducing entirely new product types. Marketing strategies must articulate clear, tangible health or performance benefits over scientific novelty. Brands should monitor MHRA guidance on novel foods closely, preparing for extended reformulation windows and higher R&D costs to secure regulatory approval and consumer buy-in. Initial product launches featuring novel ingredients may need to target younger, early-adopter demographics to establish market traction before wider distribution.
Brand owners increasingly rely on contract-manufacturing partners such as Supplement Factory to navigate these requirements.